Martingale Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2,555	Closed	-$310K	–	1014
2017 Q1	$310K	Sell	2,555 -1,029	-29%	-$133K	﹤0.01%	877
2016 Q4	$439K	Sell	3,584 -2,062	-37%	-$252K	0.01%	845
2016 Q3	$692K	Sell	5,646 -1,318	-19%	-$170K	0.01%	756
2016 Q2	$814K	Sell	6,964 -304	-4%	-$43.1K	0.01%	570
2016 Q1	$1.01M	Sell	7,268 -2,961	-29%	-$435K	0.02%	487
2015 Q4	$1.95M	Sell	10,229 -2,601	-20%	-$454K	0.04%	310
2015 Q3	$2.01M	Buy	12,830 +1,360	+12%	+$248K	0.05%	305
2015 Q2	$2.07M	Sell	11,470 -1,056	-8%	-$182K	0.05%	323
2015 Q1	$2.17M	Buy	12,526 +200	+2%	+$36.2K	0.05%	322
2014 Q4	$2.28M	Buy	12,326 +3,258	+36%	+$604K	0.06%	305
2014 Q3	$1.5M	Buy	9,068 +1,100	+14%	+$181K	0.05%	354
2014 Q2	$1.25M	Sell	7,968 -11	-0.1%	-$1.74K	0.04%	440
2014 Q1	$1.21M	Buy	7,979 +126	+2%	+$20K	0.04%	430
2013 Q4	$1.04M	Buy	7,853 +397	+5%	+$47.6K	0.04%	521
2013 Q3	$867K	Sell	7,456 -3,900	-34%	-$428K	0.03%	583
2013 Q2	$1.05M	Buy	+11,356	New	+$1.09M	0.04%	463